According to a recent publication by Meticulous Research®, the insulin pens market is anticipated to reach $6.73 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period. This growth is driven by several key factors, including the rising prevalence of diabetes, advancements in insulin pen technology, increasing preference for self-administered drug delivery systems, and the implementation of diabetes awareness initiatives worldwide.
Read More : https://www.meticulousresearch.....com/product/insulin